| Literature DB >> 33342965 |
Ryohei Toya1,2, Yosuke Sasaki3, Ryoko Uemura4, Masuo Sueyoshi2,4.
Abstract
In Japan, reducing the use of antimicrobials in pig production is a significant issue. However, there are no published reports concerning porcine disease treatment, as related to the age of the pigs and the indications (e.g., organ system) in Japan. In this study, we analyzed the prescription records of 17 farrow-to-finish farms from 2014 to 2018 in southern Kyushu, Japan. The farms' antimicrobial usage was calculated as the active ingredient per population correction unit (PCU) or the number of treated pigs per PCU using the defined daily dose. All data were analyzed according to the indications and production stages (sows, suckling pigs, post-weaning pigs, and fattening pigs). In terms of active ingredients/PCU, tetracyclines were the most commonly used (43.2-59.3%), and the largest amounts of antimicrobials administered through feeds were for treating the respiratory organs of fattening pigs. In terms of the number of treated pigs/PCU, tetracyclines were most frequently used (16.3-31.1%), and a high frequency of antimicrobials administered through feeds was used for the treatment of respiratory organs in post-weaning pigs. In this study, it was confirmed that tetracyclines were used frequently as a herd treatment for respiratory diseases in post-weaning and fattening pigs in southern Kyushu, Japan. The findings suggest that it is necessary to improve the treatment and prevention of respiratory diseases in post-weaning and fattening pigs in order to reduce the frequencies of antimicrobial treatments.Entities:
Keywords: antimicrobial usage; defined daily dose; pig; respiratory disease; tetracyclines
Mesh:
Substances:
Year: 2020 PMID: 33342965 PMCID: PMC7972880 DOI: 10.1292/jvms.20-0436
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
The maximum defined daily dose (DDD) values established in Japan
| Substance | Antimicrobial class | Route | DDD (max) | Substance | Antimicrobial class | Route | DDD (max) | ||
|---|---|---|---|---|---|---|---|---|---|
| Prenteral | Oral | ||||||||
| Oxytetracycline | Tetracyclines | Injection | 10 | Amoxicillin | Penicillins | Feed or water | 10 | ||
| Oxytetracycline LAa) | Tetracyclines | Injection | 6.67 | Ampicillin | Penicillins | Gavage, feed or water | 12 | ||
| Florfenicol | Amphenicols | Injection | 5 | Sulfadimethoxine | Sulfonamides | Feed | 80 | ||
| Thiamphenicol | Amphenicols | Injection | 30 | Sulfamonomethoxine | Sulfonamides | Feed or water | 60 | ||
| Amoxicillin LAa) | Penicillins | Injection | 7.5 | Tylosin | Macrolides | Water | 25 | ||
| Ampicillin | Penicillins | Injection | 10 | Mirosamicin | Macrolides | Feed | 4 | ||
| Aspoxicillin | Penicillins | Injection | 5 | Tylosin | Macrolides | Feed | 4.4 | ||
| Benzylpenicillin | Penicillins | Injection | 3 | Tilmicosin | Macrolides | Feed | 8 | ||
| Mecillinam | Penicillins | Injection | 5 | Tylvalosin | Macrolides | Feed | 2 | ||
| Cefazolin | Cephalosoprins | Injection | 5 | Lincomycin | Lincosamides | Water | 10 | ||
| Cefquinome | Cephalosoprins | Injection | 2 | Lincomycin | Lincosamides | Feed | 4.4 | ||
| Ceftiofur | Cephalosoprins | Injection | 3 | Gentamicin | Aminoglycosides | Water | 0.63 | ||
| Ceftiofur SDa) | Cephalosoprins | Injection | 5 | Streptomycin | Aminoglycosides | Water | 30 | ||
| Sulfadimethoxine | Sulfonamides | Injection | 100 | Gentamicin | Aminoglycosides | Gavage | 5 | ||
| Sulfamonomethoxine | Sulfonamides | Injection | 100 | Apramycin | Aminoglycosides | Feed | 4 | ||
| Erythromycin | Macrolides | Injection | 7 | Kanamycin | Aminoglycosides | Topical | 160 | ||
| Mirosamicin | Macrolides | Injection | 5 | Oxolinic acid | Quinolones | Gavage | 20 | ||
| Tilmicosin | Macrolides | Injection | 10 | Oxolinic acid | Quinolones | Feed | 20 | ||
| Tulathromycin | Macrolides | Injection | 2.5 | Orbifloxacin | Quinolones | Water | 5 | ||
| Tylosin | Macrolides | Injection | 10 | Norfloxacin | Quinolones | Feed | 10 | ||
| Lincomycin | Lincosamides | Injection | 10 | Colistin | Polymyxins | Feed | 8 | ||
| Dihydrostreptomycin (DSM) | Aminoglycosides | Injection | 100 | Tiamulin | Pleuromutilins | Water | 5.85 | ||
| Kanamycin | Aminoglycosides | Injection | 20 | Tiamulin Ab) | Pleuromutilins | Feed | 6 | ||
| Danofloxacin | Quinolones | Injection | 1.25 | Tiamulin Bb) | Pleuromutilins | Feed | 12 | ||
| Enrofloxacin | Quinolones | Injection | 2.5 | Valnemulin | Pleuromutilins | Feed | 4 | ||
| Enrofloxacin SDa) | Quinolones | Injection | 7.5 | Bicozamycin | Other antibacterials | Gavage, feed or water | 10 | ||
| Marbofloxacin | Quinolones | Injection | 2 | Chlortetracycline_Sulfadimidine | Tetracyclines (combi.) | Feed | 8 | ||
| Orbifloxacin | Quinolones | Injection | 5 | Sulfonamides (combi.) | Feed | 8 | |||
| Tiamulin | Pleuromutilins | Injection | 10 | Oxytetracycline _fradiomycin Ab) | Tetracyclines (combi.) | Feed | 10 | ||
| Fosfomycin | Other antibacterials | Injection | 20 | Aminoglycosides (combi.) | Feed | 7 | |||
| Benzylpenicillin_DSM | Penicillins (combi.) | Injection | 40 | Oxytetracycline _fradiomycin Bb) | Tetracyclines (combi.) | Feed | 9.2 | ||
| Aminoglycosides (combi.) | Injection | 7.5 | Aminoglycosides (combi.) | Feed | 7 | ||||
| Sulfadoxine_trimthoprim | Sulfonamides (combi.) | Injection | 12 | Benzylpenicillin_kanamycin | Penicillins (combi.) | Feed | 1.44 | ||
| Trimthoprim (combi.) | Injection | 25 | Aminoglycosides (combi.) | Feed | 7 | ||||
| Benzylpenicillin_streptomycin | Penicillins (combi.) | Feed | 1.44 | ||||||
| Oral | Aminoglycosides (combi.) | Feed | 7 | ||||||
| Chlortetracycline | Tetracyclines | Water | 30 | Sulfamethoxazole_trimethoprim | Sulfonamides (combi.) | Water | 10.41 | ||
| Doxycycline | Tetracyclines | Water | 24 | Trimthoprim (combi.) | Water | 2.09 | |||
| Oxytetracycline | Tetracyclines | Water | 11 | Sulfamonomethoxine_ormetoprim | Sulfonamides (combi.) | Water | 15 | ||
| Chlortetracycline | Tetracyclines | Feed | 17.6 | Trimthoprim (combi.) | Water | 5 | |||
| Doxycycline | Tetracyclines | Feed | 12 | Sulfadimethoxine_trimethoprim | Sulfonamides (combi.) | Feed | 36 | ||
| Oxytetracycline | Tetracyclines | Feed | 16 | Trimthoprim (combi.) | Feed | 4 | |||
| Florfenicol | Amphenicols | Water | 2 | Sulfamethoxazole_trimethoprim | Sulfonamides (combi.) | Feed | 6.67 | ||
| Florfenicol | Amphenicols | Feed | 2 | Trimthoprim (combi.) | Feed | 1.33 | |||
| Thiamphenicol | Amphenicols | Feed | 8 | Sulfamonomethoxine_ormetoprim | Sulfonamides (combi.) | Feed | 7.2 | ||
| Trimthoprim (combi.) | Feed | 2.4 | |||||||
a) LA: long acting, SD: single dose. b) Oxytetracycline_fradiomycin A: manufacturer N, Oxytetracycline_fradiomycin B: manufacturer P, Tiamulin A: manufacturer Z, Ka, E, Tiamulin B: manufacturer Ky, F.
Fig. 1.Changes in antimicrobial usage over 5 years by class (a), age group (b), and indication (organ system) (c). (a) The antimicrobial usage based on the active ingredient (mg)/population correcthion unit (PCU) and the numbers of treated pigs (heads)/PCU were compared. Thirteen antimicrobial classes were compared based on the WHO ATCvet classification system. In terms of active ingredients (mg)/PCU, tetracyclines (43.2–59.3%) were most frequently used, followed by sulfonamides (0.6–14.4%). While, for the number of treated pigs (heads)/PCU, tetracyclines (17.3–34.2%) were most frequently used, followed by aminoglycosides (10.4–18.8%). (b) The highest frequency of antimicrobials was used in the post-weaning stage (58.7–68.5%), followed by the fattening stage (27.3–34.6%). (c) Six indications according to the organ systems. The antimicrobials were most frequently used to treat respiratory organs (55.0–65.0%), followed by the gastrointestinal tract (33.5–42.3%).
Mean and variation of antimicrobial usage in 17 farms
| Year | n | Active ingredients(mg)/PCU | No. of treated pigs (heads)/PCU | Medication route | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Total | Through feed | Through water | Parenteral | |||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
| 2014 | 12 | 216.1 | 199.5 | 1.10 | 0.59 | 0.92 | 0.62 | 0.23 | 0.27 | 0.08 | 0.09 |
| 2015 | 14 | 242.9 | 251.4 | 1.44 | 1.85 | 1.25 | 1.84 | 0.14 | 0.25 | 0.10 | 0.11 |
| 2016 | 17 | 237.5 | 239.2 | 1.23 | 1.65 | 1.12 | 1.66 | 0.09 | 0.14 | 0.07 | 0.07 |
| 2017 | 17 | 227.1 | 227.5 | 1.13 | 1.53 | 1.00 | 1.53 | 0.12 | 0.15 | 0.06 | 0.08 |
| 2018 | 17 | 191.9 | 205.4 | 0.95 | 1.38 | 0.84 | 1.38 | 0.10 | 0.10 | 0.06 | 0.07 |
The value of mg/population correcthion unit (PCU) rounds off the second decimal point, and heads/PCU rounds third decimal point.
Fig. 2.Antimicrobial classes administered through feeds for post-weaning and fattening pigs to treat the respiratory organs and gastrointestinal tract. A different trend was seen between the active ingredient (mg)/population correcthion unit (PCU) (a) and the number of treated pigs (heads)/PCU (b). (a) The largest amounts of antimicrobials were used for treating the respiratory organs of fattening pigs (1,223.0–2,035.9 mg/PCU), followed by the respiratory organs of post-weaning pigs (632.7–1,039.4 mg/PCU). Tetracyclines were used the most to treat the respiratory organs of the fattening and post-weaning pigs (956.8–1,525.7 and 284.4–704.9 mg/PCU, respectively). (b) Respiratory organs in post-weaning pigs (3.65–7.87 heads/PCU) were treated most frequently, followed by the gastrointestinal tract of post-weaning pigs (2.76–4.75 heads/PCU) and the respiratory organs of fattening pigs (2.59–4.16 heads/PCU). Tetracyclines were used frequently for the treatment of the respiratory organs of post-weaning and fattening pigs (1.52–3.34 and 1.42–2.16 heads/PCU, respectively), and aminoglycosides were used for treating the gastrointestinal tract of post-weaning pigs (1.20–2.31 heads/PCU).